Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 3314
Journal of Biotechnology & Biomaterials received 3314 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Quercetin enhances the effect of Adriamycin in human hepatocellular carcinoma (HepG2) cell lines
6th World Congress on Biotechnology
R Venkateswari
University of Madras, India
ScientificTracks Abstracts: J Biotechnol Biomater
Abstract
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide; it is the fifth most common cancer in men and eighth most common in women. HCC results in 250000 to one million deaths globally per annum. Adriamycin is a widely used chemotherapeutic drug used to treat many different forms of cancer but causes side effects by damaging normal cells leading to cardiotoxicity and nephrotoxicity through the production of free radicals. Quercetin (3, 3�´, 4�´, 5, 7-Pentahydroxyflavone) is one of the most abundant bio-flavonoids present inedible fruits and vegetables and because of its antioxidant property can reduce the side effects caused by Adriamycin. The present study, aims to investigate the in vitro anti-tumorigenic property of quercetin along with Adriamycin in HepG2 cell lines. We examined the cell viability by MTT assay, lipid peroxidation and antioxidant enzymes like catalase, superoxide dismutase, glutathione peroxidase and glutathione reductase; marker enzymes like ALP, LDH and the gene and protein expression studies of apoptotic genes like Bcl-xl, Bcl 2, Bak, Apaf, Bax, p53, p21, caspase 3, caspase 9 and PARP in HepG2 cell line. Our study has proved that quercetin is a very effective growth inhibitor when used alone as well when used in combination with Adriamycin in HepG2 cell line. In recent years, research about quercetin has increased both in vitro and in vivo considering it as a promising anti-cancer agent.Biography
R Venkateswari has completed her PhD in Cancer Biochemistry from the University of Madras. She is currently working as an Assistant Professor in the Department of Medical Biochemistry, University of Madras since 2014. She has 19 years of teaching experience and 8 years of research experience in Vels University and University of Madras. Her area of research is on antioxidants in cancer chemotherapy, apoptosis, angiogenesis and drug discovery from medicinal plants. She has published papers in reputed journals and has been serving as an Editorial Board Member of reputed journals.
Email: vengiteja06@yahoo.co.in
